×

Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation

  • US 8,524,772 B2
  • Filed: 05/11/2009
  • Issued: 09/03/2013
  • Est. Priority Date: 05/09/2008
  • Status: Active Grant
First Claim
Patent Images

1. A composition in an oral dosage form comprising a sustained release (SR) component, wherein the SR component comprises ethyl ester of N-acetylcysteine, or a salt or solvate thereof;

  • further comprising an immediate release (IR) component, wherein the IR component comprises an ethyl ester of N-acetylclysteine or a salt or solvate thereof; and

    wherein the composition, upon oral administration, provides a therapeutically effective plasma concentration of N-acetylcysteine over more than about 2 hours following the administration.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×